ALLMedicine™ Antiepileptic Drugs Center
Research & Reviews 3,164 results
https://doi.org/10.1097/BPB.0000000000000998
Journal of Pediatric Orthopedics. Part B; Quan T, Pizzarro J et. al.
Jun 29th, 2022 - The impact of seizure disorders on pediatric patients who undergo hip dysplasia surgery has yet to be elucidated. This study focused on identifying the effect of seizure disorders on the incidence of complications following surgical management of ...
https://doi.org/10.1016/j.jpeds.2022.04.041
The Journal of Pediatrics; Espino B, Markowitz M
Jun 25th, 2022 - 50 Years Ago in TheJournalofPediatrics: Rickets and Antiepileptic Drugs: What Have We Learned?|2022|Espino B,Markowitz M,|adverse effects,drug therapy,
https://doi.org/10.3390/ijerph19127517
International Journal of Environmental Research and Publi... Kopciuch D, Fliciński J et. al.
Jun 25th, 2022 - This study assessed the differentiation of treatment costs with newer and older antiepileptic drugs (AEDs) through its correlation with treatment effectiveness and an adverse event (AE) in pediatric patients with epilepsy (PPE). PPE on monotherapy...
https://doi.org/10.1038/s41593-022-01095-5
Nature Neuroscience; Kumar P, Lim A et. al.
Jun 24th, 2022 - Epileptogenic triggers are multifactorial and not well understood. Here we aimed to address the hypothesis that inappropriate pro-inflammatory mechanisms contribute to the pathogenesis of refractory epilepsy (non-responsiveness to antiepileptic dr...
https://doi.org/10.1007/s40266-022-00948-9 10.1007/s12603-020-1447-8 10.1001/jama.2020.13484 10.1007/s40520-020-01601-4 10.1001/jamainternmed.2021.0224 10.1016/S1474-4422(20)30370-7 10.1016/j.jamda.2020.09.007 10.1016/j.regg.2008.06.001 10.1017/S104161020700484X 10.3389/fphar.2020.01168 10.1080/08039480801960172 10.1001/jama.294.15.1934 10.3233/JAD-140579 10.1176/appi.ajp.2011.11030347 10.3233/ADR-170042 10.1176/appi.ajp.2012.12030342 10.1017/S104161021600082X 10.5694/mja17.00857 10.1176/ajp.139.9.1136 10.1016/j.regg.2016.09.003 10.4088/JCP.v64n0607 10.1017/S1041610216001150 10.1017/S1041610220004032 10.1093/ageing/afl131 10.1007/s11096-016-0318-1 10.1007/s40266-016-0414-x 10.1136/bmj.e977 10.1001/jamapsychiatry.2014.3018 10.1111/jgs.14111 10.1016/j.aprim.2011.07.018 10.1111/jgs.15767 10.1001/jamainternmed.2018.0379 10.1001/archgenpsychiatry.2010.200 10.1016/j.jagp.2015.07.001 10.1136/bmj.h369 10.1017/S1041610207006540 10.1111/jgs.12730 10.1001/jamainternmed.2017.0746
Drugs & Aging; Ferro Uriguen A, Laso Lucas E et. al.
Jun 22nd, 2022 - To limit the introduction of coronavirus disease 2019 (COVID-19) into nursing homes, restrictive measures and social distancing were implemented; however, these caused an increase in affective disorders such as depression and anxiety and an altera...
Guidelines 6 results
https://doi.org/10.1212/WNL.0000000000005755
Neurology Kanner AM, Ashman E et. al.
Jun 15th, 2018 - To update the 2004 American Academy of Neurology (AAN) guideline for treating new-onset focal or generalized epilepsy with second- and third-generation antiepileptic drugs (AEDs). The 2004 AAN criteria were used to systematically review literature...
https://doi.org/10.1212/WNL.0000000000005756
Neurology Kanner AM, Ashman E et. al.
Jun 15th, 2018 - To update the 2004 American Academy of Neurology guideline for managing treatment-resistant (TR) epilepsy with second- and third-generation antiepileptic drugs (AEDs). 2004 criteria were used to systemically review literature (January 2003 to Nove...
https://doi.org/10.1111/ene.13381
European Journal of Neurology; Ferro JM, Bousser MG et. al.
Aug 24th, 2017 - Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update the previous European Federation of Neurological Societies guidelines usin...
https://doi.org/10.1111/j.1528-1167.2009.02130.x
Epilepsia Harden CL, Pennell PB et. al.
Jun 10th, 2009 - A committee assembled by the American Academy of Neurology (AAN) reassessed the evidence related to the care of women with epilepsy (WWE) during pregnancy, including preconceptional folic acid and prenatal vitamin K use and the clinical implicatio...
https://doi.org/10.1212/WNL.0b013e3181a6b325
Neurology Harden CL, Pennell PB et. al.
Apr 29th, 2009 - To reassess the evidence for management issues related to the care of women with epilepsy (WWE) during pregnancy, including preconceptional folic acid use, prenatal vitamin K use, risk of hemorrhagic disease of the newborn, clinical implications o...
Drugs 40 results see all →
Clinicaltrials.gov 232 results
https://clinicaltrials.gov/ct2/show/NCT00221988
May 18th, 2022 - III. INTRODUCTION: Background Antiepileptic Drugs And Cognitive Dysfunction Epilepsy is the most common debilitating neurologic disorder, with a prevalence of about 6/1000 in the general population (Hauser and Hesdorffer, 1990). Along with the dis...
https://clinicaltrials.gov/ct2/show/NCT03083665
May 13th, 2022 - The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in subjects (>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treat...
https://clinicaltrials.gov/ct2/show/NCT02631759
May 4th, 2022 - Haemorrhagic strokes represent about 10-15 % of all strokes and 30,000 cases per year in France. The 30-day death rate ranges from 30 to 55% (50% of deaths occurring within 48 hours). Currently, no urgent medical or surgical treatment has been sho...
https://clinicaltrials.gov/ct2/show/NCT04855578
Apr 12th, 2022 - Gabapentinoids, which include gabapentin and pregabalin, are antiepileptic drugs that have been approved by the FDA and Health Canada for the treatment of postherpetic neuralgia, with pregabalin also approved for the treatment of diabetic neuropat...
https://clinicaltrials.gov/ct2/show/NCT04253379
Apr 7th, 2022 - Epilepsy is a chronic disorder which affects 50 million people all over the world, with a childhood-onset in 75% of cases. This disorder may interfere with the normal cerebral development and impact cognition skills (Bouis, Cavézian et Chokron, 20...
News 579 results
https://www.medscape.com/viewarticle/971734
Apr 6th, 2022 - SEATTLE – Use of antiseizure medications while breastfeeding is not associated with differences in child cognitive outcomes at age 3, according to new results from the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD...
https://www.mdedge.com/neurology/article/253483/epilepsy-seizures/antiseizure-medication-appears-safe-pregnancy
Jim Kling
Apr 5th, 2022 - SEATTLE – Use of antiseizure medications while breastfeeding is not associated with differences in child cognitive outcomes at age 3, according to new results from the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD.
https://www.mdedge.com/psychiatry/article/253224/bipolar-disorder/psychiatric-and-nonpsychiatric-indications-mood
Andrew Karas, PharmD, BCPP, Lauren Stummer, PharmD, BCPP et. al.
Apr 1st, 2022 - Mr. B, age 64, is being treated in the psychiatric clinic for generalized anxiety disorder.
https://www.medscape.com/viewarticle/971158
Mar 29th, 2022 - The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in children aged 2 years and older, the c...
https://www.medscape.com/viewarticle/965756
Dec 29th, 2021 - Whole-plant cannabis is linked to a significant reduction in seizures in children with severe treatment-resistant epilepsy, early research suggests. In a small case series, children with severe treatment-resistant epilepsy treated with a range of ...